Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CHYM vs BMNR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CHYM Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

CHYM Overall Winner 6-Pillar Tally: CHYM 5 – 1 BMNR Matrix Metrics: CHYM 7 – 3 BMNR

As of Nov 16, 2026, Chime Financial, Inc. (CHYM) is the stronger overall head-to-head candidate over BitMine Immersion Technologies, Inc. (BMNR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CHYM carries a Unified Composite Score of 33.1/100 (SELL) at $34.29 (31.6x Forward P/E, 19.3% operating margin), whereas BMNR carries 47.7/100 (HOLD) at $16.26 (7.0x Forward P/E, -216.3% operating margin).

  • Composite vs. Pillar Nuance: While BMNR currently prints a higher short-term Unified Composite Score (47.7/100 HOLD vs. CHYM 33.1/100 SELL), CHYM captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (19.3% vs. -216.3% operating margin) and revenue trajectory (+32.1% vs. +4801.3% YoY).
  • Technical & Structure Timing Caution: CHYM trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 73.1); meanwhile BMNR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CHYM vs BMNR
CHYM NASDAQ Head-to-Head Winner
Chime Financial, Inc. Class A Common Stock
Finance Services
$34.29
+2.21% 1D
Market Cap $12.9B
TTM Revenue $14.3B
Forward P/E 31.6x
Beta / 30D Vol 1.44β · 36% Vol
Unified Composite Score
33.1 / 100 SELL
Tech 15.0 Fund 33.0 Flow 57.0 Mom 30.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 73
RSI-14: 73.1 · SMA20: $30.52 · SMA50: $29.94
BMNR NYSE American
BitMine Immersion Technologies, Inc.
Finance Services
$16.26
-7.51% 1D
Market Cap $11.0B
TTM Revenue $125M
Forward P/E 7.0x
Beta / 30D Vol 3.10β · 82% Vol
Unified Composite Score
47.7 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 72.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.7%), weak momentum, RSI 32
RSI-14: 31.8 · SMA20: $20.30 · SMA50: $23.22

6-Pillar Scorecard Institutional Category Breakdown (CHYM 5 – 1 BMNR)

Columns: Metric · CHYM · BMNR
1. Valuation Multiples CHYM
Forward P/E 31.6x 7.0x
Trailing P/E 29.4x N/M
PEG Ratio N/M N/M
EV / Revenue 0.7x 83.9x
2. Growth & Scale BMNR
Revenue Growth (YoY) +32.1% +4801.3%
Earnings Growth (YoY) -33.8% +27.7%
TTM Revenue (USD) $14.3B $125M
Market Cap $12.9B $11.0B
3. Profitability & Quality CHYM
Gross Margin 89.4% 85.3%
Operating Margin 19.3% -216.3%
Net Profit Margin 3.0% 0.0%
Return on Equity (ROE) 5.4% -52.4%
4. Balance Sheet & Cash Flow CHYM
Cash Generation (TTM) $2.27B -$305M
Cash Flow Margin 15.8% N/A
Net Cash / Leverage $2.77B Net Cash $544M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CHYM
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 48.7% (12th %ile) 108.9% (100th %ile)
Put/Call OI Skew 0.22x (Call-Skewed) 1.13x (Balanced)
OBV Trend / Tech Phase ACCUMULATION · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat CHYM
OpEx & R&D Intensity 70.1% of Rev ($10.1B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Application Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CHYM (7) vs BMNR (3)
Institutional Metric CHYM BMNR Criterion Row Edge
Market Capitalization
Scale
$12.9B $11.0B Larger Scale CHYM
Trailing P/E Ratio
Valuation
29.4x N/M Lower Multiple CHYM
Forward P/E Ratio
Valuation
31.6x 7.0x Lower Multiple BMNR
Revenue Growth (YoY)
Growth
+32.1% +4801.3% Higher Growth BMNR
Operating Margin (TTM)
Profitability
19.3% -216.3% Higher Margin CHYM
Net Profit Margin
Profitability
3.0% 0.0% Higher Margin CHYM
Return on Equity (ROE)
Capital Efficiency
5.4% -52.4% Higher ROE CHYM
52-Week Range Position
Momentum
94% ($16–$36) 13% ($13–$40) Stronger Trend CHYM
Beta / 30D Volatility
Risk Regime
1.44β · 36% Vol 3.10β · 82% Vol Lower Realized Risk CHYM
Unified Institutional Score
Composite Signal
33.1 / 100 (SELL) 47.7 / 100 (HOLD) Higher Composite BMNR
Trailing 12M Revenue (USD)
Operating Scale
$14.3B $125M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
89.4% 85.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.7x EV/Rev N/M PEG · 83.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$2.27B ($2.77B Net Cash) -$305M ($544M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CHYM +40.5 pp
CHYM: +15.57% · BMNR: -24.93%
3M Horizon CHYM +18.51 pp
CHYM: +7.46% · BMNR: -11.05%
6M Horizon CHYM +108.57 pp
CHYM: +95.38% · BMNR: -13.19%
1Y Horizon CHYM +134.23 pp
CHYM: +78.69% · BMNR: -55.54%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CHYM Revenue BMNR Revenue CHYM Op. Margin BMNR Op. Margin Margin Leader
FY2022 N/A $0M N/A -400.8% BMNR
FY2023 $1.28B $0M -18.4% -374.0% CHYM
FY2024 $1.67B $0M -3.7% -74.0% CHYM
FY2025 $2.19B $10M -47.6% 7288.1% BMNR
FY2026 N/A $120M N/A -5207.4% BMNR

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CHYM CONSOLIDATION
48d in phase · OBV ACCUMULATION
Current IV 48.7%
IV Percentile 12th %ile
Put/Call OI Skew 0.22x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact CHYM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BMNR BREAKDOWN
39d in phase · OBV DISTRIBUTION
Current IV 108.9%
IV Percentile 100th %ile
Put/Call OI Skew 1.13x (Balanced)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact BMNR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $34.29 · IV 48.7%

CHYM vs. BMNR: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of CHYM ($3,429) vs. BMNR ($1,626) against risk-defined 5-day vertical and put-wall option structures.

CHYM Spot $34.29 · IV 48.7%
CHYM Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $35 / $37.5 Bull Call Spread

Buy 1x $35C · Sell 1x $37.5C · 32d

Net Entry $91 Debit
T+5d @ +5% Move +$32 (+35%)
Max Risk / Buffer $91 Capped
5d Edge & Liquidity 0.8x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Jan 15 '27 $30 / $27.5 Bull Put Spread

Sell 2x $30P · Buy 2x $27.5P · 60d

Net Entry $90 Credit
Max Credit / Yield +$90 (+22.0% RoM)
Max Risk / Buffer -13.8% Cushion ($410 Mgn)
5d Edge & Liquidity 79% PoP · Liq B
Simulate 5-Day Payoff →
BMNR Spot $16.26 · IV 86.1%
BMNR Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $17 / $20 Bull Call Spread

Buy 1x $17C · Sell 1x $20C · 32d

Net Entry $91 Debit
T+5d @ +5% Move +$16 (+18%)
Max Risk / Buffer $91 Capped
5d Edge & Liquidity 0.6x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Dec 18 $15 / $14 Bull Put Spread

Sell 4x $15P · Buy 4x $14P · 32d

Net Entry $132 Credit
Max Credit / Yield +$132 (+49.3% RoM)
Max Risk / Buffer -9.8% Cushion ($268 Mgn)
5d Edge & Liquidity 68% PoP · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CHYM Moat Profile Scale & Operating Efficiency Moat
Software - Application Operator
Competes within the Software - Application value chain with $12.9B market capitalization and 19.3% operating margin.
OpEx & R&D Reinvestment 70.1% of Rev ($10.1B)
90D Engineering Disclosures 0 Published
BMNR Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $11.0B market capitalization and -216.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CHYM vs BMNR Key Questions & Quantitative Answers

As of Nov 16, 2026, Chime Financial, Inc. (CHYM) is the stronger overall head-to-head candidate over BitMine Immersion Technologies, Inc. (BMNR) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CHYM carries a Unified Composite Score of 33.1/100 (SELL) at $34.29 (31.6x Forward P/E, 19.3% operating margin), whereas BMNR carries 47.7/100 (HOLD) at $16.26 (7.0x Forward P/E, -216.3% operating margin). Composite vs. Pillar Nuance: While BMNR currently prints a higher short-term Unified Composite Score (47.7/100 HOLD vs. CHYM 33.1/100 SELL), CHYM captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (19.3% vs. -216.3% operating margin) and revenue trajectory (+32.1% vs. +4801.3% YoY). Technical & Structure Timing Caution: CHYM trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 73.1); meanwhile BMNR is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BMNR leads the Growth & Scale pillar: CHYM posts +32.1% YoY revenue growth and -33.8% YoY earnings growth on $14.3B TTM revenue (89.4% gross margin, 19.3% operating margin), compared with BMNR at +4801.3% YoY revenue growth and +27.7% YoY earnings growth on $125M TTM revenue (85.3% gross margin, -216.3% operating margin). Across the 5-period historical trajectory (FY2022 to FY2026), CHYM cumulative revenue shifted +71.1% while BMNR shifted +1100.0%. In operating R&D and SG&A reinvestment, CHYM deploys 70.1% of Rev ($10.1B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BMNR.

CHYM screens cheaper on headline valuation multiples. CHYM trades at 31.6x Forward P/E, 29.4x Trailing P/E, N/M PEG, and 0.7x EV/Revenue (15.8% FCF margin), whereas BMNR trades at 7.0x Forward P/E, N/M Trailing P/E, N/M PEG, and 83.9x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CHYM (5.4% ROE) versus BMNR (-52.4% ROE) capital efficiency.

In options market volatility and institutional positioning, CHYM carries 48.7% implied volatility (12th %ile, Compressed (<25th %ile)), a 0.22x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.44β · 36% Vol realized risk). By comparison, BMNR carries 108.9% implied volatility (100th %ile, Extreme (>80th %ile)), a 1.13x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.10β · 82% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.